Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -290,073 | -360,395 | -89,225 | -106,014 | -57,649 |
| Depreciation Amortization | 19,050 | 11,926 | 10,229 | 9,035 | 5,125 |
| Accounts receivable | 31,639 | -35,689 | -4,144 | 1,364 | 1,982 |
| Accounts payable and accrued liabilities | 1,676 | 8,840 | 1,832 | -1,736 | -3,512 |
| Other Working Capital | 35,116 | -29,401 | -8,118 | -8,965 | -55,928 |
| Other Operating Activity | 13,452 | 239,078 | 20,769 | -9,293 | 22,914 |
| Operating Cash Flow | $-189,140 | $-165,641 | $-68,657 | $-115,609 | $-87,068 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -306,900 | -514,853 | -126,499 | 11,884 | 83,250 |
| PPE Investments | -12,950 | -8,961 | -4,006 | -8,348 | -1,291 |
| Net Acquisitions | N/A | -25,000 | N/A | N/A | N/A |
| Other Investing Activity | -1,471 | 0 | 0 | -162 | 0 |
| Investing Cash Flow | $-321,321 | $-548,814 | $-130,505 | $3,374 | $81,959 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 616,555 | 752,457 | 202,315 | 93,771 | 738 |
| Common Stock Repurchased | -378 | -15,992 | -1,389 | -359 | 0 |
| Financing Cash Flow | $616,177 | $736,465 | $200,926 | $93,412 | $738 |
| Beginning Cash Position | 75,179 | 53,169 | 51,405 | 70,228 | 74,599 |
| End Cash Position | 180,895 | 75,179 | 53,169 | 51,405 | 70,228 |
| Net Cash Flow | $105,716 | $22,010 | $1,764 | $-18,823 | $-4,371 |
| Free Cash Flow | |||||
| Operating Cash Flow | -189,140 | -165,641 | -68,657 | -115,609 | -87,068 |
| Capital Expenditure | -12,950 | -8,961 | -4,006 | -8,348 | -1,291 |
| Free Cash Flow | -202,090 | -174,602 | -72,663 | -123,957 | -88,359 |